Australia - English - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct886 - reagent red blood cell ivds - the test is based on hemagglutination principles. reagent red blood cells with specific antigens agglutinate in the presence of corresponding antibodies contained in donor plasma. the absence of agglutination indicates the absence of the specific antibody in the donor plasma. the analyzers read the settling patterns and make a determination. the beckman coulter? pk? system reagent red blood cels (a1 and b) are intended for the determination of the reverse or plasma group on the beckman coulter pk7200 and pk7300 automated analyzers.

Australia - English - Department of Health (Therapeutic Goods Administration)

immulab pty ltd - ct886 - reagent red blood cell ivds - agglutination and/or haemolysis of the reagent red blood cell, in one or more techniques demonstrates the presence of clinically relevant antibodies in patient serum/plasma samples. 1. antibody screening 2. antibody identification 3. reverse grouping

Australia - English - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct886 - reagent red blood cell ivds - the pk system blood grouping and phenotyping reagents are intended for the determination of blood abo group and rh type and kell phenotypes in blood donors using the beckman coulter pk7300 and/or the beckman coulter pk7400 automated microplate system(s). the pk system blood grouping and phenotyping reagents are intended for the determination of blood abo group and rh type and kell phenotypes in blood donors using the beckman coulter pk7300 and/or the beckman coulter pk7400 automated microplate system(s).

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

biomerieux s.a, france - analytical reagents -

Australia - English - Department of Health (Therapeutic Goods Administration)

bio-rad laboratories pty ltd - ct886 - reagent red blood cell ivds - reagent red cells are human red blood cells diluted to either 3% or 0.8% and are used to identify patient antibodies to red cell antigens.the reagent red cells have known red cells antigens that allow for the identification of unknown patient antibodies. specifically characterised reagent red blood cells that are intended to be used in immunohaematological testing due to the known specificity of their red cell antigens.